Do gut hormones contribute to weight loss and glycaemic outcomes after bariatric surgery?
D Papamargaritis, CW le Roux - Nutrients, 2021 - mdpi.com
Bariatric surgery is an effective intervention for management of obesity through treating
dysregulated appetite and achieving long-term weight loss maintenance. Moreover …
dysregulated appetite and achieving long-term weight loss maintenance. Moreover …
Differences in alimentary glucose absorption and intestinal disposal of blood glucose after Roux-en-Y gastric bypass vs sleeve gastrectomy
JB Cavin, A Couvelard, R Lebtahi, R Ducroc, K Arapis… - Gastroenterology, 2016 - Elsevier
Background & Aims Bariatric procedures, such as Roux-en-Y gastric bypass (RYGB) or
vertical sleeve gastrectomy (VSG), are the most effective approaches to resolve type 2 …
vertical sleeve gastrectomy (VSG), are the most effective approaches to resolve type 2 …
Relationship between gut hormones and glucose homeostasis after bariatric surgery
PC Sala, RS Torrinhas, D Giannella-Neto… - Diabetology & metabolic …, 2014 - Springer
Type 2 diabetes mellitus (T2D) is emerging as a worldwide public health problem, and is
mainly associated with an increased incidence of obesity. Bariatric surgery is currently …
mainly associated with an increased incidence of obesity. Bariatric surgery is currently …
Assessing the state of obesity care: Quality, access, guidelines, and standards
LM Kaplan, CM Apovian, JD Ard… - Obesity Science & …, 2024 - Wiley Online Library
Background An international panel of obesity medicine experts from multiple professional
organizations examined patterns of obesity care and current obesity treatment guidelines to …
organizations examined patterns of obesity care and current obesity treatment guidelines to …
Fasting circulating glicentin increases after bariatric surgery
Introduction Bariatric surgery including the Roux-en-Y gastric bypass (RYGB) and the
laparoscopic sleeve gastrectomy (LSG) is a well-established therapeutic option for patients …
laparoscopic sleeve gastrectomy (LSG) is a well-established therapeutic option for patients …
Time to glycemic control-an observational study of 3 different operations
A Celik, S Pouwels, FC Karaca, E Çağıltay, S Ugale… - Obesity surgery, 2017 - Springer
Background Medical treatment fails to provide adequate control for many obese patients
with type 2 diabetes mellitus (T2DM). A comparative observational study of bariatric …
with type 2 diabetes mellitus (T2DM). A comparative observational study of bariatric …
Type 2 diabetes mellitus outcomes after laparoscopic gastric bypass in patients with BMI <35 kg/m2 using strict remission criteria: early outcomes of a prospective …
O Espinosa, O Pineda, HG Maydón, EM Sepúlveda… - Surgical …, 2018 - Springer
Abstract Background Mild obesity (BMI 30–34.9 kg/m 2) is highly prevalent worldwide and is
associated with type 2 diabetes mellitus. The efficacy of bariatric surgery remains unclear …
associated with type 2 diabetes mellitus. The efficacy of bariatric surgery remains unclear …
DPP-IV, an important target for antidiabetic functional food design
Type 2 diabetes mellitus is a chronic metabolic disease that is characterized by
hyperglycemia, which results from the body's ineffective use of insulin (a gradual decline in …
hyperglycemia, which results from the body's ineffective use of insulin (a gradual decline in …
Metabolic profiles, energy expenditures, and body compositions of the weight regain versus sustained weight loss patients who underwent Roux-en-Y gastric bypass
PC Shantavasinkul, P Omotosho… - Surgery for Obesity and …, 2021 - Elsevier
Background Weight regain (WR) has been an emerging problem after Roux-en Y gastric
bypass (RYGB) and little is known about the mechanisms of WR after RYGB. Objective To …
bypass (RYGB) and little is known about the mechanisms of WR after RYGB. Objective To …
Structural changes of gut microbiota after gastric bypass in obese patients with type 2 diabetes
M Lang, KH Zheng, SH Zeng, Y Yang… - … Fang yi ke da xue xue …, 2017 - europepmc.org
Objective To investigate the structural changes inintestinal flora and metabolic changes in
type 2 diabetic patients with obesity (BMI≥ 40 kg/m 2) by sequencing the 16S rRNA genes …
type 2 diabetic patients with obesity (BMI≥ 40 kg/m 2) by sequencing the 16S rRNA genes …